Polymorphisms of metabolizing enzymes and susceptibility to ethmoid intestinal-type adenocarcinoma in professionally exposed patients

Translational Oncology

Volumn 2, Issue 2, 2009, Pages 84-88

  Pastore, Elisa ^a   Perrone, Federica ^a   Orsenigo, Marta ^a   Mariani, Luigi ^a   Millefanti, Clara ^a   Riccio, Stefano ^a   Colombo, Sarah ^a   Cantù, Giulio ^a   Pierotti, Marco A ^a   Pilotti, Silvana ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; XENOBIOTIC AGENT;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CODON; DNA POLYMORPHISM; DUST; ENZYME METABOLISM; ETHMOID INTESTINAL ADENOCARCINOMA; FEMALE; GENE INTERACTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEATHER INDUSTRY; MALE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; WOOD;

EID: 77953442475     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.08226     Document Type: Article

References (29)

1. Donhuijsen K, Hattenberger S, and Schroeder HG (2004). Nasal sinus carcinoma after wood dust exposure. Morphological spectrum of 100 cases. Pathologe 25, 14-20.
2. Acheson ED (1976). Nasal cancer in the furniture and boot and shoe manufacturing industries. Prev Med 5, 295-315.
3. Luce D, Leclerc A, Morcet JF, Casal-Lareo A, Gérin M, Brugère J, Haguenoer JM, and Goldberg M (1992). Occupational risk factors for sinonasal cancer: a case-control study in France. Am J Ind Med 21, 163-175.
4. Cantu G, Solero CL, Mariani L, Salvatori P, Mattavelli F, Pizzi N, and Riggio E (1999). Anterior craniofacial resection for malignant ethmoid tumors - a series of 91 patients. Head Neck 21, 185-191.
5. Lund VJ, Howard DJ, Wei WI, and Cheesman AD (1998). Craniofacial resection for tumors of the nasal cavity and paranasal sinuses - a 17-year experience. Head Neck 20, 97-105.
6. Roux FX, Pages JC, Nataf F, Devaux B, Laccourreye O, Menard M, and Brasnu D (1997). Malignant ethmoid-sphenoidal tumors. 130 cases. Retrospective study. Neurochirurgie 43, 100-110.
7. McCutcheon IE, Blacklock JB, Weber RS, DeMonte F, Moser RP, Byers M, and Goepfert H (1996). Anterior trancranial (craniofacial) resection of tumors of the paranasal sinuses: surgical technique and results. Neurosurgery 38, 471-480.
8. Richtsmeier WJ, Briggs RJ, Koch WM, Eisele DW, Loury MC, Price JC, Mattox DE, and Carson BS (1992). Complications and early outcome of anterior craniofacial resection. Arch Otolaryngol Head Neck Surg 118, 913-917.
9. Shah JP, Kraus DH, Bilsky MH, Gutin PH, Harrison LH, and Strong EW (1997). Craniofacial resection for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg 123, 1312-1317.
10. Choussy O, Ferron C, Védrine PO, Toussaint B, Liétin B, Marandas P, Babin E, De Raucourt D, Reyt E, Cosmidis A, et al. (2008). Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases. Laryngoscope 118, 437-443.
11. Licitra L, Suardi S, Bossi P, Locati LD, Mariani L, Quattrone P, Lo Vullo S, Oggionni M, Olmi P, Cantù G, et al. (2004). Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma. J Clin Oncol 22, 4901-4906.
12. Cascorbi I, Brockmoller J, and Roots I (1996). A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56, 965-969.
13. Hayashi SI, Watanabe J, Nakachi K, and Kawajiri K (1991). PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 19, 4797.
14. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, Ookuma R, and Bell DA (1996). Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17, 1855-1859.
15. Lafuente A, Pujol F, Carretero P, Villa JP, and Cuchi A (1993). Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 68, 49-54.
16. Sato M, Sato T, Izumo T, and Amagasa T (2000). Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral Oncol 36, 267-271.
17. Matthias C, Bockmuhl U, Jahnke V, Jones PW, Hayes JD, Alldersea J, Gilford J, Bailey L, Bath J, Worrall SF, et al. (1998). Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 8, 91-100.
18. Kiyohara C, Wakai K, Mikami H, Sido K, Ando M, and Ohno Y (2003). Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. Int J Cancer 107, 139-144.
19. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, and Vainio H (1992). Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev 1, 485-489.
20. Slattery ML, Samowitz W, Ma K, Murtaugh M, Sweeney C, Levin TR, and Neuhausen S (2004). CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol 160, 842-852.
21. INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Int J Cancer 105, 196-203.
22. Frattini M, Perrone F, Suardi S, Balestra D, Caramuta S, Colombo F, Licitra L, Cantù G, Pierotti MA, and Pilotti S (2006). Phenotype-genotype correlation: challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Head Neck 28, 909-915.
23. Gronau S, Koenig-Greger D, Jerg M, and Riechelmann H (2003). GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis 9, 62-67.
24. Greenblatt MS, Bennett WP, Hollstein M, and Harris CC (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54, 4855-4878.
25. Schwarz D, Kisselev P, Cascorbi I, Schunck WH, and Roots I (2001). Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis 22, 453-459.
26. Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, and Singh MP (2007). A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Breast Cancer Res Treat 101, 73-81.
27. Kisselev P, Schunck WH, Roots I, and Schwarz D (2005). Association of CYP1A1 polymorphisms with differential metabolic activation of 17beta-estradiol and estrone. Cancer Res 65, 2972-2978.
28. Martínez JG, Pérez-Escuredo J, López F, Suárez C, Alvarez-Marcos C, Llorente JL, and Hermsen MA (2009). Microsatellite instability analysis of sinonasal carcinomas. Otolaryngol Head Neck Surg 140, 55-60.
29. Hermsen MA, Llorente JL, Pérez-Escuredo J, López F, Ylstra B, Alvarez-Marcos C, and Suárez C (2009). Genome-wide analysis of genetic changes in intestinaltype sinonasal adenocarcinoma. Head Neck 31, 290-297.